nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Clinical development of Modified Vaccinia virus Ankara vaccines
|
Gilbert, Sarah C. |
|
2013 |
31 |
39 |
p. 4241-4246 6 p. |
artikel |
2 |
Editorial Board/Aims and Scope
|
|
|
2013 |
31 |
39 |
p. CO2- 1 p. |
artikel |
3 |
Modified Vaccinia virus Ankara: Innate immune activation and induction of cellular signalling
|
Price, Philip J.R. |
|
2013 |
31 |
39 |
p. 4231-4234 4 p. |
artikel |
4 |
Oncolytic myxoma virus: The path to clinic
|
Chan, Winnie M. |
|
2013 |
31 |
39 |
p. 4252-4258 7 p. |
artikel |
5 |
Poxvirus vectors
|
Kreijtz, Joost H.C.M. |
|
2013 |
31 |
39 |
p. 4217-4219 3 p. |
artikel |
6 |
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies
|
Volz, Asisa |
|
2013 |
31 |
39 |
p. 4235-4240 6 p. |
artikel |
7 |
Recombinant MVA vaccines: dispelling the myths
|
Cottingham, Matthew G. |
|
2013 |
31 |
39 |
p. 4247-4251 5 p. |
artikel |
8 |
Reflections on the early development of poxvirus vectors
|
Moss, Bernard |
|
2013 |
31 |
39 |
p. 4220-4222 3 p. |
artikel |
9 |
Regulation of poxvirus vectored vaccines
|
Robertson, James S. |
|
2013 |
31 |
39 |
p. 4259-4260 2 p. |
artikel |
10 |
Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects
|
Draper, Simon J. |
|
2013 |
31 |
39 |
p. 4223-4230 8 p. |
artikel |